Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 36, 2014 - Issue 3
321
Views
8
CrossRef citations to date
0
Altmetric
Original Research Papers

Improvement of cognitive deficits in SAMP8 mice by 3-n-butylphthalide

, , &

References

  • Effros RB, Austad S, Blau H. The biological sciences section program at the 60th Annual Meeting of the Gerontological Society of America. J Gerontol A Biol Sci Med Sci. 2008;63:331–7.
  • Mayeux R, Sano M. Treatment of Alzheimer’s disease. N Engl J Med. 1999;341:1670–9.
  • Peng Y, Xu S, Chen G, Wang L, Feng Y, Wang X. l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Pharmacol Exp Ther. 2007;321:902–10.
  • Xu HL, Feng YP. Effects of D-3-n-butylphthalide (NBP) on pial arterioles in focal cerebral ischemia rats. Acta Pharm Sin. 1999;34:172–5.
  • Peng Y, Xu SF, Wang L. Effect of l-3-n-butylphthalide on cerebral infarct volume in the transient cerebral ischemia rats. Chin J New Drug. 2005; 14: 420–3.
  • Xiong J, Feng YP. Effects of butylphthalide on the activities of complexes of the mitochondrial respiratory chain. Acta Pharm Sin. 1999;34:241–5.
  • Dong GX, Feng YP. Effects of NBP on ATPase and anti-oxidant enzymes activities and lipid peroxidation in transient focal cerebral ischemic rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002;24:93–7.
  • Chang Q, Wang XL. Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin. 2003;24:796–804.
  • Xu HL, Feng YP. Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacol Sin. 2000;21:433–8.
  • Zhang T, Jia WP, Sun XJ. 3-n-butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats. Neurol Res. 2010;32:390–6.
  • Takeda T, Hosokawa M, Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of senescence. Exp Gerontol. 1997;32:105–9.
  • Takeda T. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res. 2009;34:639–59.
  • Takeda T, Josokawa M, Takeshita S, Irino M, Higuchi M, Matsushita T, . A new murine model of accelerated senescence. Mech Ageing Dev. 1981;17:183–94.
  • Zhang YX, Moriguchi T, Saito H, Nishiyama N. Functional relationship between age-related immunodeficiency and learning deterioration. Eur J Neurosci. 1998;10:3869–75.
  • Cheng HY, Yu JC, Jiang ZG, Zhang XZ, Liu CZ, Peng YM, . Acupuncture improves cognitive deficits and regulates the brain cell proliferation of SAMP8 mice. Neurosci Lett. 2008;432:111–6.
  • Rodriguez MI, Escames G, Lopez LC, Lopez A, Garcia JA, Ortiz F, . Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol. 2008;43(8):749–56.
  • Petursdottir AL, Farr SA, Morley JE, Banks WA, Skuladottir GV. Lipid peroxidation in brain during aging in the senescence-accelerated mouse (SAM). Neurobiol Aging. 2007;28:1170–8.
  • Strong R, Reddy V, Morley JE. Cholinergic deficits in the septal-hippocampal pathway of the SAM-P/8 senescence accelerated mouse. Brain Res. 2003;966:150–6.
  • Wang F, Chen H, Sun XJ. Age-related spatial cognitive impairment is correlated with a decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice. Neurosci Lett. 2009;454:212–7.
  • Onozuka M, Watanabe K, Nagasaki S, Jiang Y, Ozono S, Nishiyama K, . Impairment of spatial memory and changes in astroglial responsiveness following loss of molar teeth in aged SAMP8 mice behavior. Behav Brain Res. 2000;108:145–55.
  • Fischer W, Wictorin K, Björklund A. Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur J Neurosci. 1989;2:34–45.
  • Gallagher M, Burwell RD, Kodsi MH, McKinney M, Southerland S, Vella-Rountree L. Markers for biogenic amines in the aged rat brain: relationship to decline in spatial learning ability. Neurobiol Aging. 1990;11:507–14.
  • Sasaki K, Tooyama I, Li AJ, Oomura Y, Kimura H. Effects of an acidic fibroblast growth factor fragment analog on learning and memory and on medial septum cholinergic neurons in senescence accelerated mice. Neuroscience. 1999;92:1287–94.
  • Ke ZJ, Bowen WM, Gibson GE. Peripheral inflammatory mechanisms modulate microglial activation in response to mild impairment of oxidative metabolism. Neurochem Int. 2006;49:548–56.
  • Onozuka M, Watanabe K, Fujita M, Tomida M, Ozono S. Changes in the septohippocampal cholinergic system following removal of molar teeth in the aged SAMP8 mouse behavior. Brain Res. 2002;133:197–204.
  • Ke ZJ, DeGiorqio LA, Volpe BT, Gibson GE. Reversal of thiamine deficiency-induced neurodegeneration. J Neuropathol Exp Neurol. 2003;62:195–207.
  • Paxinos G, Franklin K. The mouse brain in stereotaxic coordinates, compact 2nd edn. New York: Academic Press; 2003.
  • Janus C, Amelio D, Amitay S, Chishti MA, Strome R, Fraser P. Spatial learning in transgenic mice expressing human presenilin (PS1) transgenes. Neurobiol Aging. 2000;21:541–9.
  • Backman L. Memory and cognition in preclinical dementia: what we know and what we do not know. Can J Psychiatry. 2008;53:354–60.
  • Serrano PA, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:a006189.
  • Khairallah MI, Kassem LA. Alzheimer’s disease: current status of etiopathogenesis and therapeutic strategies. Pak J Biol Sci. 2011;14(4):257–72.
  • Takeda T, Matsushita T, Kurozumi M, Takemura K, Higuchi K, Hosokawa M. Pathobiology of the senescence-accelerated mouse (SAM). Exp Gerontol. 1997;32:117–27.
  • Morley JE, Farr SA, Kumar VB, Armbrecht HJ. The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. Curr Pharm Des. 2012;18(8):1123–30.
  • Morley JE, Armbrecht HJ, Farr SA, Kumar VB. The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer’s disease. Biochim Biophys Acta. 2012;1822:650–6.
  • Harold D, Macgregor S, Patterson CE, Hollingworth P, Moore P, Owen MJ, . A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease. Pharmacogenet Genomics. 2006;16:75–7.
  • Nitta A, Naruhashi K, Umemura M, Hasegawa T, Furukawa S, Sekiguchi F, . Age-related changes in learning and memory and cholinergic neuronal function in senescence accelerated mice (SAM). Behav Brain Res. 1996;72:49–55.
  • Okuma Y, Nornura Y. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biology approach. Jpn J Pharmacol. 1998;78:399–404.
  • Lee YA, Cho EJ, Yokozawa T. Oligomeric proanthocyanidins improve memory and enhance phosphorylation of vascular endothelial growth factor receptor-2 in senescence-accelerated mouse prone/8. Br J Nutr. 2010;103:479–89.
  • Zhao HF, Li Q, Zhang ZF, Pei XR, Wang JB, Li Y. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus. Brain Res. 2009;1256:111–22.
  • Matsui N, Takahshi K, Takeichi M, Kuroshita T, Noguchi K, Yamazaki K, . Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res. 2009;1305:108–17.
  • Peng Y, Hu Y, Xu S, Li P, Li J, Lu L, . l-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice. J Alzheimers Dis. 2012;29(2):379–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.